Seroprevalence of herpes virus 1 and 2 in a Population-Based Cohort in Japan

Seroprevalence of herpes virus 1 and 2 in a Population-Based Cohort in Japan

Yasufumi Doi

1 team of treatment and hospital practice, grad school of hospital Sciences, Kyushu University, Fukuoka, Japan

2 office of environment medication, Graduate School of Medical Sciences, Kyushu school, Fukuoka, Japan

Toshiharu Ninomiya

2 office of ecological Medicine, Graduate School of health Sciences, Kyushu college, Fukuoka, Japan

Jun Hata

2 office of eco drug, grad school of Medical Sciences, Kyushu University, Fukuoka, Japan

Koji Yonemoto

2 section of environment medication, grad school of healthcare Sciences, Kyushu University, Fukuoka, Japan

Yumihiro Tanizaki

2 Department of ecological treatments, grad school of healthcare Sciences, Kyushu college, Fukuoka, Japan

Hisatomi Arima

2 section of ecological drug, Graduate School of Medical sugar daddy edinburgh Sciences, Kyushu University, Fukuoka, Japan

Ying Liu

3 Across The Globe Epidemiology, GlaxoSmithKline R&D, Tokyo, Japan

Mahbubur Rahman

4 Institution of Florida Health Branch, Galveston, Nevada, USA

Misuo Iida

1 division of Therapy and Clinical discipline, grad school of hospital Sciences, Kyushu college, Fukuoka, Japan

Yutaka Kiyohara

2 team of environment treatments, grad school of Medical Sciences, Kyushu institution, Fukuoka, Japan

Abstract

Background

There’ve been number of population-based researches on the seroprevalence and correlates of herpes virus form 1 (HSV-1) and type 2 (HSV-2) in Japan. Read more…